Edwards Lifesciences's management is eyeing partnerships with hospitals across China to introduce the therapy. Industry Prospects Per a report by Research And Markets, the global TAVR market is projected to see a CAGR of approximately 12.7% to reach $7.78 billion from 2020 to 2024. Factors like rising prevalence of AS and increasing preference of minimally-invasive surgeries are expected to drive the market. Given the market potential, the approval seems well-timed. Recent Developments in TAVR Arm Of late, Edwards Lifesciences has been witnessing a slew of developments in its business arm.